Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial

被引：0

作者：

Chuong, M. ^{[1
]}

Parikh, P. ^{[2
]}

Low, D. ^{[3
]}

Kim, J. ^{[2
]}

Mittauer, K. ^{[1
]}

Bassetti, M. ^{[4
]}

Glide-Hurst, C. ^{[4
]}

Raldow, A. ^{[3
]}

Yang, Y. ^{[3
]}

Portelance, L. ^{[5
]}

Zaki, B. ^{[6
]}

Kim, H. ^{[7
]}

Mancias, J. ^{[8
]}

Ng, J. ^{[9
]}

Pfeffer, R. ^{[10
]}

Mueller, A. ^{[11
]}

Kelly, P. ^{[12
]}

Boldrini, L. ^{[13
]}

Fuss, M. ^{[14
]}

Lee, P. ^{[15
]}

机构：

[1] Miami Canc Inst, Radiat Oncol, Miami, FL USA

[2] Henry Ford Hlth Canc, Radiat Oncol, Detroit, MI USA

[3] UCLA, Radiat Oncol, Los Angeles, CA USA

[4] Univ Wisconsin, Radiat Oncol, Madison, WI USA

[5] Univ Miami, Radiat Oncol, Miami, FL USA

[6] Dartmouth Hitchcock Med Ctr, Radiat Oncol, Lebanon, NH USA

[7] Washington Univ, Radiat Oncol, Sch Med St Louis, St Louis, MO USA

[8] Dana Farber Canc Inst, Radiat Oncol, Boston, MA USA

[9] Weill Cornell Med, Radiat Oncol, Sandra & Edward Meyer Canc Ctr, New York, NY USA

[10] Assuta Med Ctr, Radiat Oncol, Tel Aviv, Israel

[11] Thomas Jefferson Univ, Radiat Oncol, Philadelphia, PA USA

[12] Orlando Hlth Canc Inst, Radiat Oncol, Orlando, FL USA

[13] Fdn Policlin Univ A Gemelli IRCCS, Radiat Oncol, Rome, Italy

[14] ViewRay Inc, Radiat Oncol, Denver, CO USA

[15] City Hope Natl Med Ctr, Radiat Oncol, Los Angeles, CA USA

来源：

RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OC-0099

引用

页码：S61 / S61

页数：1

共 50 条

[31] Multi-institutional outcomes of patients aged 75 years and older with pancreatic ductal adenocarcinoma treated with ablative 5-fraction stereotactic magnetic resonance image-guided adaptive radiation therapy (SMART)
Chuong, Michael David
Palm, Russell
Herrera, Roberto
Rubens, Muni
Bryant, John Michael
Hoffe, Sarah E.
Kim, Dae Won
Kaiser, Adeel
Ucar, Antonio
Fleming, Jason B.
De Zarraga, Fernando I.
Hodul, Pamela Joy
Aparo, Santiago
Asbun, Horacio
Malafa, Mokenge Peter
Jimenez, Ramon
Denbo, Jason
Frakes, Jessica M.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[32] Interim Toxicity Analysis From the Randomized HERMES Trial of 2-and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy
Westley, Rosalyne Laura
Biscombe, Katie
Dunlop, Alex
Mitchell, Adam
Oelfke, Uwe
Nill, Simeon
Murray, Julia
Pathmanathan, Angela
Hafeez, Shaista
Parker, Chris
Ratnakumaran, Ragu
Alexander, Sophie
Herbert, Trina
Hall, Emma
Tree, Alison C.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (03): : 682 - 687
[33] A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes
Azoulay, Melissa
Chang, Steven D.
Gibbs, Iris C.
Hancock, Steven L.
Pollom, Erqi L.
Harsh, Griffith R.
Adler, John R.
Harraher, Ciara
Li, Gordon
Gephart, Melanie Hayden
Nagpal, Seema
Thomas, Reena P.
Recht, Lawrence D.
Jacobs, Lisa R.
Modlin, Leslie A.
Wynne, Jacob
Seiger, Kira
Fujimoto, Dylann
Usoz, Melissa
von Eyben, Rie
Choi, Clara Y. H.
Soltys, Scott G.
NEURO-ONCOLOGY, 2020, 22 (08) : 1182 - 1189
[34] Surgical outcomes after neoadjuvant ablative dose radiation among patients with borderline resectable and locally advanced pancreas cancer from the multi-institutional phase 2 Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) trial.
Parikh, Parag
Asbun, Domenech
Chuong, Michael David
Portelance, Lorraine
Datta, Jashodeep
Bassetti, Michael F.
Weber, Sharon M.
Zaki, Bassem I.
Smith, Kerrington D.
Raldow, Ann C.
Donahue, Timothy R.
Kim, Hyun
Hawkins, William G.
Kelly, Patrick
Low, Daniel
Lee, Percy
Fuss, Martin
Kwon, David S.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 718 - 718
[35] Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
Bryant, J. M.
Palm, Russell F.
Herrera, Roberto
Rubens, Muni
Hoffe, Sarah E.
Kim, Dae Won
Kaiser, Adeel
Ucar, Antonio
Fleming, Jason
De Zarraga, Fernando
Hodul, Pamela
Aparo, Santiago
Asbun, Horacio
Malafa, Mokenge
Jimenez, Ramon
Denbo, Jason
Frakes, Jessica M.
Chuong, Michael D.
CANCER CONTROL, 2023, 30
[36] Phase 2 Trial of Stereotactic MRI-guided Adaptive Radiation Therapy in One Fraction (SMART ONE)
Chuong, Michael D.
Mittauer, Kathryn E.
Bassetti, Michael
Glide-Hurst, Carri K.
Rojas, Carolina
Kalman, Noah
Tom, Martin
Rubens, Muni
Alvarez, Diane
Crosby, Jennie
McCulloch, James
Burr, Adam
Gutierrez, Alonso N.
Bassiri-Gharb, Nema
Mehta, Minesh P.
Kotecha, Rupesh
RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1960 - S1962
[37] Phase 2 Trial of Stereotactic MR-Guided Adaptive Radiation Therapy in One Fraction (SMART ONE)
Chuong, M. D.
Mittauer, K. E.
Bassetti, M. F.
Glide-Hurst, C.
Rojas, C.
Kalman, N. S.
Tom, M. C.
Rubens, M.
Crosby, J.
Burr, A.
Gutierrez, A.
Bassiri-Gharb, N.
Mehta, M. P.
Kotecha, R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S163 - S164
[38] Acute Quality of Life Changes After Stereotactic Ablative Radiation Therapy for Liver Metastasis: A Prospective Cohort Analysis
Helou, J.
Thibault, I.
Chu, W.
Munoz, P.
Erler, D.
Rodrigues, G.
Warner, A.
Chan, K.
Chow, E.
Korol, R.
Davidson, M. T.
Chung, H. T.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E533 - E534
[39] Impact of the Radiation Therapy Quality Assurance in the phase II/III CONCORDE trial.
Lopez, H.
Crehange, G.
Blanc, J.
M'vondo, C.
Pereira, R.
Rio, E.
Peiffert, D.
Gnep, K.
Benezery, K.
Ronchin, P.
Noel, G.
Mineur, L.
Drouillard, A.
Rouffiac, M.
Boustani, J.
Bertaut, A.
Huguet, F.
RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S82 - S83
[40] Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases
Franceschini, D.
Teriaca, M. A.
Mancosu, P.
Bertolini, A.
Lo Faro, L.
Spoto, R.
Dominici, L.
Badalamenti, M.
Bellu, L.
Dei, D.
La Fauci, F.
Franzese, C.
Scorsetti, M.
RADIOTHERAPY AND ONCOLOGY, 2024, 197

← 1 2 3 4 5 →